{"id":16912,"date":"2022-04-25T12:11:41","date_gmt":"2022-04-25T16:11:41","guid":{"rendered":"https:\/\/www.emilysentourage.org\/?p=16912"},"modified":"2022-05-03T13:46:02","modified_gmt":"2022-05-03T17:46:02","slug":"178882-awarded-in-funding-for-cystic-fibrosis-research","status":"publish","type":"post","link":"https:\/\/www.emilysentourage.org\/tr\/178882-awarded-in-funding-for-cystic-fibrosis-research\/","title":{"rendered":"EE Kistik Fibrozis Ara\u015ft\u0131rmalar\u0131 i\u00e7in $178,882 Fon Sa\u011flad\u0131\u011f\u0131n\u0131 Duyurdu"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">\u015eubat 2022'de, Emily's Entourage'\u0131n (EE) <\/span><a href=\"https:\/\/www.emilysentourage.org\/tr\/440000-awarded-in-round-6-funding-for-cystic-fibrosis-research\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">$440,000 fon sa\u011fland\u0131<\/span><\/a><span style=\"font-weight: 400;\"> Kistik fibrozis (KF) ara\u015ft\u0131rmalar\u0131n\u0131 ve ila\u00e7 geli\u015ftirmeyi ilerletmek i\u00e7in iki yeni hibe i\u00e7in. Bug\u00fcn, EE'nin \u00fc\u00e7\u00fcnc\u00fc bir hibe al\u0131c\u0131s\u0131 olan Mitochon Pharmaceuticals, Inc. \u015firketine, KF'li ki\u015filerde mitokondriyal disfonksiyon ara\u015ft\u0131rmalar\u0131n\u0131 ilerletmek i\u00e7in ek $178,882 verdi\u011fini payla\u015fmaktan heyecan duyuyoruz.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bu hibeye ili\u015fkin ek bilgiler a\u015fa\u011f\u0131da yer almaktad\u0131r.<\/span><\/p>\n<h2><strong>HIBE ALICISI:<\/strong><\/h2>\n<hr \/>\n<h3 style=\"padding-left: 40px;\"><b>MP-101'in kistik fibrozis i\u00e7in terap\u00f6tik faydas\u0131<br \/>\n<\/b><\/h3>\n<p style=\"padding-left: 40px;\"><img decoding=\"async\" class=\"alignleft wp-image-16915 size-thumbnail\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Dr.-Geisler-1-150x150.png\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Dr.-Geisler-1-150x150.png 150w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Dr.-Geisler-1.png 300w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Dr.-Geisler-1-12x12.png 12w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Dr.-Geisler-1-100x100.png 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/p>\n<p style=\"padding-left: 40px;\"><img decoding=\"async\" class=\"wp-image-16919 size-thumbnail alignleft\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Robert-Alonso-150x150.png\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Robert-Alonso-150x150.png 150w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Robert-Alonso.png 300w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Robert-Alonso-12x12.png 12w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Headshot-Robert-Alonso-100x100.png 100w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/p>\n<p><span style=\"font-weight: 400;\">John G. Geisler, PhD, CSO ve kurucu ortak (solda)<\/span><br \/>\n<span style=\"font-weight: 400;\">Robert Alonso, MBA, CEO ve kurucu ortak (sa\u011fda)<\/span><\/p>\n<p style=\"padding-left: 40px;\"><i><span style=\"font-weight: 400;\">Mitochon Pharmaceuticals, Inc.<\/span><\/i><\/p>\n<p style=\"padding-left: 40px;\"><span style=\"font-weight: 400;\">Mitokondriyal disfonksiyon, KF'li ki\u015filerde s\u0131kl\u0131kla g\u00f6zden ka\u00e7an bir sorundur. Bozulmu\u015f enerji \u00fcretimi ve v\u00fccuttaki t\u00fcm h\u00fccreler i\u00e7in toksik olan \u00e7ok y\u00fcksek seviyelerde serbest radikallerin olu\u015fumu ile belirgindir. Mitochon'un \u00e7al\u0131\u015fmas\u0131, serbest radikal \u00fcretimini ve mitokondriyal kalsiyum a\u015f\u0131r\u0131 y\u00fcklenmesini azaltmak, b\u00f6ylece enflamatuar tepkileri ve bunun sonucunda olu\u015fan doku hasar\u0131n\u0131 azaltmak i\u00e7in bir mitokondriyal mod\u00fclat\u00f6r olan MP-101'in kullan\u0131m\u0131nda KF i\u00e7in yeni bir yakla\u015f\u0131m\u0131 temsil etmektedir. MP-101 bir KF gelincik modelinde test edilecek ve ba\u015far\u0131l\u0131 olmas\u0131 halinde KF'li hastalarda da denenebilecek. <\/span><\/p>\n<hr \/>\n<p><span style=\"font-weight: 400;\">Alt\u0131nc\u0131 turun di\u011fer iki hibe al\u0131c\u0131s\u0131 hakk\u0131nda bilgi edinin, <\/span><a href=\"https:\/\/www.emilysentourage.org\/tr\/440000-awarded-in-round-6-funding-for-cystic-fibrosis-research\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">\u015eubat 2022'de duyuruldu<\/span><\/a><span style=\"font-weight: 400;\">\u00c7al\u0131\u015fmalar\u0131 yeni bir sa\u00e7ma mutasyon gelincik modeli ve lipid nanopartik\u00fcller kullanan yeni bir gen terapisi formunun geli\u015ftirilmesine odaklanmaktad\u0131r.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">KF'li t\u00fcm insanlar i\u00e7in kar\u015f\u0131lanmam\u0131\u015f kritik ihtiya\u00e7lar\u0131n h\u0131zl\u0131 bir \u015fekilde kar\u015f\u0131lanmas\u0131na \u00f6nc\u00fcl\u00fck eden t\u00fcm adanm\u0131\u015f bilim insanlar\u0131na minnettar\u0131z - kimse geride kalmas\u0131n! G\u00f6r\u00fcnt\u00fcle a <\/span><a href=\"https:\/\/www.emilysentourage.org\/tr\/awarded-grants\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">kapsaml\u0131 liste<\/span><\/a><span style=\"font-weight: 400;\"> Verilen t\u00fcm ara\u015ft\u0131rma hibelerinin<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>\u015eubat 2022'de Emily's Entourage'\u0131n (EE) kistik fibrozis (KF) ara\u015ft\u0131rmalar\u0131n\u0131 ve ila\u00e7 geli\u015ftirmeyi ilerletmek amac\u0131yla iki yeni hibe i\u00e7in $440,000 fon sa\u011flad\u0131\u011f\u0131n\u0131 duyurmu\u015ftuk. Bug\u00fcn, EE'nin \u00fc\u00e7\u00fcnc\u00fc bir hibe al\u0131c\u0131s\u0131 olan Mitochon Pharmaceuticals, Inc. \u015firketine, bu hastalardaki mitokondriyal disfonksiyon ara\u015ft\u0131rmalar\u0131n\u0131 ilerletmek i\u00e7in ek $178,882 verdi\u011fini payla\u015fmaktan heyecan duyuyoruz. <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/www.emilysentourage.org\/tr\/178882-awarded-in-funding-for-cystic-fibrosis-research\/\" class=\"excerpt-read-more\">Daha fazla bilgi edinin<\/a><\/p>","protected":false},"author":1281,"featured_media":16960,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"EE Announces $178,882 in Funding for Cystic Fibrosis Research","_seopress_titles_desc":"We are thrilled to share that EE has awarded an additional $178,882 to a third grant recipient, Mitochon Pharmaceuticals, Inc., to advance research into mitochondrial dysfunction in those with CF.","_seopress_robots_index":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"jetpack_featured_media_url":"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/mitochon.png","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts\/16912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/users\/1281"}],"replies":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/comments?post=16912"}],"version-history":[{"count":5,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts\/16912\/revisions"}],"predecessor-version":[{"id":16920,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts\/16912\/revisions\/16920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/media\/16960"}],"wp:attachment":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/media?parent=16912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/categories?post=16912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/tags?post=16912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}